Dimitrios Diamandidis works in the field of Hematology. He attended Aristotle University of Thessaloniki School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dimitrios Diamandidis is a published doctor as well. He has 2 publications published. The latest was: Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results. Dr. Dimitrios T. Diamandidis is registered with Medicare.
|
Dr. Nikolaos Touroutoglou, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Shamoon Ahmad, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Noel M. Rowan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Clark S. Jean, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenneth A. Foon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Karen S. Jacks, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph Quagliana, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Carlos W. Araujo, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. M Nafees Nagy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Yupo Ma, MD
|
|
Dr. Phillip J. Manno, MD
This Doctor is OpenDoctor Recommended.
|